Aethlon Medical, Inc. (OTCQB: AEMD), announced today that the United States Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier@ in the United States. The...
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has submitted a Premarket Approval (PMA) application to the U.S. Food...
Applimotion has introduced custom gear motors for your high torque low speed and low profile applications. The assemblies combine precision gearing and direct drive frameless motor kits to form a new high torque alternative to coupling a servo motor to a traditional gear box.
Having just celebrated six competitive years in business - Cambus Medical has launched a series of cutting edge technological advances in the medical device market including the pioneering Navigate program, a contract product development service which aids customers through the entire product development cycle.
ICCNexergy has announced the release of the U1LiFe long-life Lithium Iron Phosphate (LiFePO4) medical cart battery portfolio. ICCNexergy’s U1LiFe battery portfolio is specifically designed for mobile medical cart applications that require longer runtime, faster charge time, consistent power, and longer service life.
Pittman Motors has introduced its latest offering in a broad range of DC brush and brushless motors. The BI-05 Series slotless brushless DC motor is designed for maximum precision and performance in a package size perfectly suited for precision equipment.
Bacterial DNA may integrate into the human genome more readily in tumors than in normal human tissue, scientists have found. The researchers, affiliated with the University of Maryland School of Medicine's Institute for Genome Sciences, analyzed genomic sequencing data available from the Human Genome Project, the 1,000 Genomes Project and The Cancer Genome Atlas.
Japanese researchers have developed a new sugar and water-based solution that turns tissues transparent in just three days, without disrupting the shape and chemical nature of the samples. Combined with fluorescence microscopy, this technique enabled them to obtain detailed images of a mouse brain at an unprecedented resolution.
Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the completion of its acquisition of Palomar Medical Technologies, Inc. Cynosure purchased Palomar in a cash and stock transaction valued...
Emergency department information systems (EDIS), a significant focus of both federal legislation and U.S. healthcare reform, may ultimately improve the quality of medical care delivered in hospitals, but as currently configured, present numerous threats to healthcare quality and patient safety.
A new method of maturing human heart cells that simulates the natural growth environment of heart cells while applying electrical pulses to mimic the heart rate of fetal humans has led researchers at the University of Toronto to an electrifying step forward for cardiac research.
Medical electronic devices are no longer a trend; they are the reality of today’s healthcare environment. Seemingly, the number of powered medical devices far exceeds their non-powered counterparts. Even devices that had traditionally not been powered, such as the stethoscope, are now either being replaced by more effective electronic devices or being updated with electronics to function more efficiently and, more simply, better.
Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider, operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today reported that it has launched DoctorInPocket or Zhang Shang Hao Yi, in Chinese, a mobile health application.
Imagine a swarm of tiny devices only a few hundred nanometers in size that can detect trace amounts of toxins in a water supply or the very earliest signs of cancer in the blood. Now imagine that these tiny sensors can reset themselves, allowing for repeated use over time inside a body of water – or a human body.
Doctors are reporting a major step toward an "artificial pancreas," a device that would constantly monitor blood sugar in people with diabetes and automatically supply insulin as needed. A key component of such a system—an insulin pump programmed to shut down if blood-sugar dips too low while people are sleeping—worked as intended in a three-month study of 247 patients.